Early RA MRI Early Intensive Treatment Study

Early Rheumatoid Arthritis Clinical Trial

Official title:
Effect of Early Intensive Treatment in Chinese Patients With Recent-onset Rheumatoid Arthritis

Status Completed

Clinical Trial Summary

To compare the effectiveness of two treatment strategies in early rheumatoid arthritis (ERA), namely the delayed usual care and early intensive care, in Hong Kong. - The delayed usual care reflects the usual treatment practice in Hong Kong - The early intensive care includes tight monitoring and immediate adjustment of therapy

Clinical Trial Description

This study is a 1-year non-randomized clinical trial. Two groups of patients (delayed usual care and early intensive care) with diagnosis of rheumatoid arthritis (RA) and with symptoms onset of less than 2 years and disease modifying anti-rheumatic drugs (DMARDs) naive will be recruited. Remission is reached if patients fulfill the Boolean criteria. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01762176
Study type	Interventional
Source	Chinese University of Hong Kong
Contact
Status	Completed
Phase	N/A
Start date	October 2012
Completion date	July 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01768923` - Early RA Vascular Randomised Controlled Study	N/A
Completed	`NCT01185301` - Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA)	Phase 3
Recruiting	`NCT03755258` - Trial of Ginsenoside Compound K (GCK) Tablet in Patients With Rheumatoid Arthritis	Phase 1
Recruiting	`NCT03389711` - INCMNSZ - Rheumatoid Arthritis Cohort
Completed	`NCT00195663` - Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis	Phase 3
Completed	`NCT04752748` - Power Doppler in Hand Joints of Early RA Patients